Physician profile
Debralee Williams
NPI 1700574415
$5,123.22
in general payments reported to CMS, 2019-2025
8 companies · $453 in 2025
The $453 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $809 · 2024: $3,862 · 2025: $453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,755 · Travel and Lodging: $2,324 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,754.66 |
| Travel and Lodging | $2,323.56 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,623.88 | 2023-2025 | Wavewriter Alpha Prime 16 |
| Nalu Medical, INC. | $1,329.03 | 2024-2025 | Nalu Neurostimulation System |
| Medtronic, INC. | $727.88 | 2023-2025 | Synchromedii, Vectris Surescan |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $132.75 | 2023-2024 | Relistor |
| Collegium Pharmaceutical, INC. | $94.80 | 2023-2024 | Belbuca |
| Averitas Pharma INC. | $88.01 | 2024-2025 | Qutenza |
| Pfizer INC. | $84.24 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $42.63 | 2024-2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debralee Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.